Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's disease.
Saved in:
| Title: | Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's disease. |
|---|---|
| Authors: | Roblin X; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI (Centre International de Recherche en Infectiologie), Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, France., Veyrard P; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Bastide L; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Berger AE; CIRI (Centre International de Recherche en Infectiologie), Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, France.; Immunology Laboratory, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France., Barrau M; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Paucelle AS; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Waeckel L; CIRI (Centre International de Recherche en Infectiologie), Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, France.; Immunology Laboratory, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France., Kwiatek S; Departemnt of Gastroenterology CHU Reunion, France., Flourie B; CIRI (Centre International de Recherche en Infectiologie), Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, France.; Department of Gastroenterology, Lyon Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1, Lyon, France., Nancey S; CIRI (Centre International de Recherche en Infectiologie), Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, France.; Department of Gastroenterology, Lyon Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1, Lyon, France., Paul S; CIRI (Centre International de Recherche en Infectiologie), Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, France.; Immunology Laboratory, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Jul; Vol. 56 (1), pp. 77-83. Date of Electronic Publication: 2022 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
